{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T23:25:36Z","timestamp":1774308336809,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Emergency Medicine"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.ajem.2024.08.011","type":"journal-article","created":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T02:22:50Z","timestamp":1723256570000},"page":"7-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["The effect of intravenous ondansetron on QT interval in the emergency department"],"prefix":"10.1016","volume":"85","author":[{"given":"Huriye","family":"Y\u00fcr\u00fck M\u0131s\u0131rl\u0131o\u011flu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elif","family":"\u00d6zt\u00fcrk \u0130nce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meltem","family":"Akka\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ajem.2024.08.011_bb0005","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jemermed.2009.08.060","article-title":"Antiemetic therapy for nausea and vomiting in the emergency department","volume":"39","author":"Patanwala","year":"2010","journal-title":"J Emerg Med"},{"key":"10.1016\/j.ajem.2024.08.011_bb0010","series-title":"FDA drug safety communication: abnormal heart rhythms may be associated with use of Zofran (ondansetron)","author":"Food, U. and D. Administration","year":"2011"},{"key":"10.1016\/j.ajem.2024.08.011_bb0015","series-title":"Ondansetron (Zofran): important new intravenous dose restriction","year":"2012"},{"key":"10.1016\/j.ajem.2024.08.011_bb0020","first-page":"2012","article-title":"FDA drug safety communication: abnormal heart rhythms may be associated with use of Zofran (ondansetron)","volume":"29","author":"Food","year":"2015","journal-title":"June"},{"issue":"4","key":"10.1016\/j.ajem.2024.08.011_bb0025","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/pan.12339","article-title":"The effect of sevoflurane and ondansetron on QT interval and transmural dispersion of repolarization in children","volume":"24","author":"Lee","year":"2014","journal-title":"Pediatr Anesthes"},{"issue":"6","key":"10.1016\/j.ajem.2024.08.011_bb0030","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1097\/00000542-200506000-00006","article-title":"Prolongation of QTc interval after postoperative nausea and vomiting treatment by droperidol or ondansetron","volume":"102","author":"Charbit","year":"2005","journal-title":"Anesthesiol: J American Soc Anesthesiol"},{"issue":"1","key":"10.1016\/j.ajem.2024.08.011_bb0035","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4103\/0976-9668.82306","article-title":"Evaluation of ondansetron-induced QT interval prolongation in the prophylaxis of postoperative emesis","volume":"2","author":"Gupta","year":"2011","journal-title":"J Nat Sci Biol Med"},{"issue":"7","key":"10.1016\/j.ajem.2024.08.011_bb0040","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jclinane.2014.02.011","article-title":"Effects of prophylactic ramosetron and ondansetron on corrected QT interval during general anesthesia","volume":"26","author":"Kim","year":"2014","journal-title":"J Clin Anesth"},{"issue":"2","key":"10.1016\/j.ajem.2024.08.011_bb0045","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/ALN.0b013e31817fd8c8","article-title":"Droperidol and ondansetron-induced QT interval ProlongationA clinical drug interaction study","volume":"109","author":"Charbit","year":"2008","journal-title":"Anesthesiol: J American Soc Anesthesiol"},{"key":"10.1016\/j.ajem.2024.08.011_bb0050","first-page":"53","article-title":"Effect of intravenous ondansetron on QT interval prolongation in patients with cardiovascular disease and additional risk factors for torsades: a prospective, observational study","volume":"3","author":"Hafermann","year":"2011","journal-title":"Drug, Healthc Patient Safet"},{"key":"10.1016\/j.ajem.2024.08.011_bb0055","first-page":"353","article-title":"An analysis of the time relations of electrocardiograms","volume":"7","author":"Bazett","year":"1920","journal-title":"Heart"},{"key":"10.1016\/j.ajem.2024.08.011_bb0060","unstructured":"https:\/\/www.gsk-studyregister.com\/en\/trial-details\/?id=115458. Adresinden 18.02.2020 tarihinde edinilmi\u015ftir. 18.02.2020."},{"key":"10.1016\/j.ajem.2024.08.011_bb0065","series-title":"FDA drug safety communication: new information regarding QT prolongation with ondansetron (Zofran)","author":"Food, U. and D. Administration","year":"2012"},{"issue":"3","key":"10.1016\/j.ajem.2024.08.011_bb0070","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/pch\/16.3.177","article-title":"Emergency department use of oral ondansetron for acute gastroenteritis-related vomiting in infants and children","volume":"16","author":"Cheng","year":"2011","journal-title":"Paediatr Child Health"},{"issue":"1","key":"10.1016\/j.ajem.2024.08.011_bb0075","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/PEC.0000000000000757","article-title":"Effect of intravenous ondansetron on the QT interval of Patients\u2019 electrocardiograms","volume":"34","author":"Krammes","year":"2018","journal-title":"Pediatr Emerg Care"},{"issue":"1","key":"10.1016\/j.ajem.2024.08.011_bb0080","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/acem.12836","article-title":"Intravenous ondansetron and the QT interval in adult emergency department patients: an observational study","volume":"23","author":"Moffett","year":"2016","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.ajem.2024.08.011_bb0085","series-title":"Mayo Clinic proceedings","article-title":"Perioperative doses of ondansetron or dolasetron do not lengthen the QT interval","author":"Obal","year":"2014"},{"issue":"5","key":"10.1016\/j.ajem.2024.08.011_bb0090","first-page":"276","article-title":"Effect of a single dose of iv ondansetron on QTc interval in emergency department patients","volume":"75","author":"Li","year":"2018","journal-title":"Bull American Soc Hospit Pharm"},{"key":"10.1016\/j.ajem.2024.08.011_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.amsu.2021.102971","article-title":"Investigation role of ondansetron on long QT interval among non-cardiac patients","volume":"71","author":"Tabrizi","year":"2021","journal-title":"Ann Med Surgery"},{"issue":"7","key":"10.1016\/j.ajem.2024.08.011_bb0100","doi-asserted-by":"crossref","first-page":"e317","DOI":"10.1097\/PCC.0000000000000776","article-title":"Effect of ondansetron on QT interval in patients cared for in the PICU","volume":"17","author":"Trivedi","year":"2016","journal-title":"Pediatr Crit Care Med"},{"issue":"9","key":"10.1016\/j.ajem.2024.08.011_bb0105","first-page":"740","article-title":"Detailed analysis of the impact of age on the QT interval","volume":"13","author":"Rabkin","year":"2016","journal-title":"J Geriatr Cardiol: JGC"},{"issue":"1","key":"10.1016\/j.ajem.2024.08.011_bb0110","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/PEC.0000000000000757","article-title":"Effect of intravenous ondansetron on the QT interval of patients\u2019 electrocardiograms","volume":"34","author":"Krammes","year":"2018","journal-title":"Pediatr Emerg Care"},{"key":"10.1016\/j.ajem.2024.08.011_bb0115","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/BF03346265","article-title":"QT interval, cardiovascular risk factors and risk of death in diabetes","volume":"27","author":"Veglio","year":"2004","journal-title":"J Endocrinol Invest"},{"issue":"990","key":"10.1016\/j.ajem.2024.08.011_bb0120","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1136\/pgmj.2007.064048","article-title":"Cardiac autonomic neuropathy in diabetes mellitus: prevalence, risk factors and utility of corrected QT interval in the ECG for its diagnosis","volume":"84","author":"Pappachan","year":"2008","journal-title":"Postgrad Med J"},{"issue":"4","key":"10.1016\/j.ajem.2024.08.011_bb0125","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S0002-9149(96)00797-7","article-title":"Relation of left ventricular mass and QT dispersion in patients with systematic hypertension","volume":"79","author":"Ichkhan","year":"1997","journal-title":"Am J Cardiol"}],"container-title":["The American Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073567572400398X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073567572400398X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T04:12:25Z","timestamp":1730347945000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073567572400398X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":25,"alternative-id":["S073567572400398X"],"URL":"https:\/\/doi.org\/10.1016\/j.ajem.2024.08.011","relation":{},"ISSN":["0735-6757"],"issn-type":[{"value":"0735-6757","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of intravenous ondansetron on QT interval in the emergency department","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajem.2024.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}